Envoy Medical, Inc.COCH
Key ratios
FCF / Sales
-10488.0%TTM
2025
-7626.3%2024
-8412.4%2023
-5456.8%
ROA
-86.5%TTM
2025
-137.3%2024
-121.5%2023
-212.0%
Revenue growth
-6.8%TTM
2025
7.1%2024
-28.8%2023
33.3%
Recent news
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim Cochlear Implant
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
Track COCH in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer